Angiotensin II-induced renal responses in anesthetized rabbits: Effects of N(omega-)nitro-L-arginine methyl ester and losartan

被引:9
作者
Adachi, Y [1 ]
Hashimoto, K [1 ]
Hisa, H [1 ]
Yoshida, M [1 ]
SuzukiKusaba, M [1 ]
Satoh, S [1 ]
机构
[1] TOHOKU UNIV,INST PHARMACEUT,DEPT PHARMACOL,SENDAI,MIYAGI 98077,JAPAN
关键词
angiotensin II; nitric oxide (NO); losartan; L-NAME (N-omega-nitro-L-arginine methyl ester); kidney; (rabbit);
D O I
10.1016/0014-2999(96)00298-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intrarenal arterial infusion of angiotensin II (4 ng/kg/min) reduced renal blood flow, glomerular filtration rate and urinary Na+ excretion (UNaV) without affecting fractional Na+ excretion (FENa) in anesthetized rabbits. Losartan (10 mu g/kg/min) abolished these angiotensin II-induced renal responses. The renal blood flow, glomerular filtration rate and UNaV responses were potentiated during intrarenal arterial infusion of N-omega-nitro-L-arginine methyl ester (L-NAME, 10 mu g/kg/min). A high dose of L-NAME (50 mu g/kg/min) also potentiated the renal blood flow and UNaV responses but not the glomerular filtration rate response. Angiotensin II reduced FENa during L-NAME infusion at either dose. In L-NAME-pretreated rabbits, losartan abolished the angiotensin ii-induced renal blood flow and glomerular filtration rate responses, but the reduction in FENa still remained. The present study suggests that in the rabbit kidney (1) nitric oxide attenuates the angiotensin II-induced (angiotensin AT1 receptor-mediated) vasoconstriction and (2) angiotensin II can evoke losartan-resistant tubular Na+ reabsorption, but the tubular action is concealed by nitric oxide.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 28 条
[21]   INHIBITION OF RENAL NITRIC-OXIDE SYNTHESIS WITH N(G)-MONOMETHYL-L-ARGININE AND N(G)-NITRO-L-ARGININE [J].
NAESS, PA ;
KIRKEBOEN, KA ;
CHRISTENSEN, G ;
KIIL, F .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (06) :F939-F942
[22]   EDRF-ANGIOTENSIN-II INTERACTIONS IN RAT JUXTAMEDULLARY AFFERENT AND EFFERENT ARTERIOLES [J].
OHISHI, K ;
CARMINES, PK ;
INSCHO, EW ;
NAVAR, LG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :F900-F906
[23]   MECHANISMS OF ANGIOTENSIN-II NATRIURESIS AND ANTINATRIURESIS [J].
OLSEN, ME ;
HALL, JE ;
MONTANI, JP ;
GUYTON, AC ;
LANGFORD, HG ;
CORNELL, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (02) :F299-F307
[24]   CHARACTERIZATION OF 3 INHIBITORS OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE INVITRO AND INVIVO [J].
REES, DD ;
PALMER, RMJ ;
SCHULZ, R ;
HODSON, HF ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :746-752
[25]  
SIGMON DH, 1994, J AM SOC NEPHROL, V4, P1675
[26]  
TAKENAKA T, 1993, J AM SOC NEPHROL, V4, P1046
[27]   ROLE OF ENDOTHELIUM-DERIVED RELAXING FACTOR IN REGULATION OF RENAL HEMODYNAMIC-RESPONSES [J].
TOLINS, JP ;
PALMER, RMJ ;
MONCADA, S ;
RAIJ, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :H655-H662
[28]   IDENTIFICATION OF AN ENDOTHELIAL-LIKE TYPE-III NO SYNTHASE IN LLC-PK1 KIDNEY EPITHELIAL-CELLS [J].
TRACEY, WR ;
POLLOCK, JS ;
MURAD, F ;
NAKANE, M ;
FORSTERMANN, U .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01) :C22-C28